Table 1.
Correlation between the clinicopathologic variables and expression of p53R2 in LSC
| Variable | Expression of p53R2 | |||
|---|---|---|---|---|
| All cases | Low expression | High expression | P valuea | |
| Age (years)b | 0.084 | |||
| ≤ 57 | 47 | 24 (51.1%) | 23 (48.9%) | |
| > 57 | 53 | 18 (34.0%) | 35 (66.0%) | |
| Gender | 0.782 | |||
| Male | 87 | 37 (42.5%) | 50 (57.5%) | |
| Female | 13 | 5 (38.5%) | 8 (61.5%) | |
| Tumor sizec | 0.928 | |||
| ≤ 4.5 | 59 | 25 (42.4%) | 34 (57.6%) | |
| > 4.5 | 41 | 17 (41.5%) | 24 (58.5%) | |
| Smoking | 0.144 | |||
| Yes | 76 | 35 (46.1%) | 41 (53.9%) | |
| No | 24 | 7 (29.2%) | 17 (70.8%) | |
| T stage | 0.155 | |||
| T1 And T2 | 56 | 27 (48.2%) | 29 (51.8%) | |
| T3 And T4 | 44 | 15 (34.1%) | 29 (65.9%) | |
| Lymph node | 0.638 | |||
| N0 | 52 | 23 (44.2%) | 29 (55.8%) | |
| N1,N2 And N3 | 48 | 19 (39.6%) | 29 (60.4%) | |
| M stage | 0.310 | |||
| M0 | 92 | 40 (43.5%) | 52 (56.5%) | |
| M1 | 8 | 2 (25.0%) | 6 (75.0%) | |
| Clinical stage | 0.038 | |||
| I-II | 45 | 24 (53.3%) | 21 (46.7%) | |
| III-IV | 55 | 18 (32.7%) | 37 (67.3%) | |
| Therapyd | 0.996 | |||
| Therapy1 | 76 | 32 (42.1%) | 44 (57.9%) | |
| Therapy2 | 19 | 8 (42.1%) | 11 (57.9%) | |
| Therapy3 | 5 | 2 (40.0%) | 3 (60.0%) | |
| Relapse | 0.479 | |||
| Yes | 30 | 11 (36.7%) | 19 (63.3%) | |
| No | 70 | 31 (44.3%) | 39 (55.7%) | |
aChi-square test
bMean age
cMean tumor size
dTherapy:Therapy1 is Pneumonectomy and lymphadenectomy,Therapy2 is Pneumonectomy;Therapy3 Pneumonectomy and radiotherapy and chemoradiotherapy